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OBJECTIVES: The aim of the present study was to establish the frequency of metabolic disorders among patients
with sudden deafness and to compare this frequency with data from population surveys.
INTRODUCTION: No consensus has been reached regarding the prevalence of metabolic disorders among sudden
deafness patients or their influence as associated risk factors.
METHODS: This cross-sectional study enrolled all sudden deafness patients treated in the Otolaryngology
Department of the University of Sa ˜o Paulo between January 1996 and December 2006. Patients were subjected
to laboratory exams including glucose and cholesterol levels, low-density lipoprotein cholesterol fraction,
triglycerides, free T4 and TSH.
RESULTS: The sample comprised 166 patients. We observed normal glucose levels in 101 (81.5%) patients and
hyperglycemia in 23 (18.5%) patients, which is significantly different (p , 0.0001) compared to the diabetes mellitus
prevalence (7.6%) in the Brazilian population. Cholesterol levels were normal in 78 patients (49.7%) and abnormal
in 79 (50.3%) patients, which is significantly different compared to the Brazilian population (p = 0.0093). However,
no differences were observed in low-density lipoprotein cholesterol fraction (p = 0.1087) or triglyceride levels
(p = 0.1474) between sudden hearing loss patients and the Brazilian population. Normal levels of thyroid hormones
were observed in 116 patients (78.4%), and abnormal levels were observed in 32 (21.6%) patients. Compared with
the prevalence of thyroid disorders in the general population (10%), statistical analysis revealed a significant
difference (p = 0.0132) between these two groups.
DISCUSSION: Among sudden deafness patients, we observed frequencies of hyperglycemia and thyroid disorders
that were more than twice those of the general population.
CONCLUSIONS: Hyperglycemia and thyroid disorders are much more frequent in patients with sudden deafness
than in the general population and should be considered as important associated risk factors.
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INTRODUCTION
Sudden hearing loss (SHL) is defined as sensorineural
hearing loss of greater than 30 dB over at least three
contiguous pure-tone frequencies occurring within three
days’ period.
1 Although many etiologies have been pro-
posed for this disorder, the etiology can be identified in only
10 to 15% of cases.
1 The inner ear can be directly affected by
variations in serum insulin as well as by oscillations in
plasma glucose levels.
2 A health survey in the USA that
employed a cross-sectional analysis of nationally represen-
tative data showed that hearing impairment was more
prevalent among adults with diabetes than among those
without.
3 Previous studies have shown that auditory
function can be affected by lipid metabolism, and serum
cholesterol levels have been implicated as a significantly
associated acquired risk factor in the SHL population.
4-5 The
effects of serum thyroid hormone levels have also been
correlated with human auditory function; dynamic changes
in hearing have been recorded during the development of
hyper- and hypofunction of the thyroid gland.
6 The
incidence of deafness in cretinism is 35%, and hearing loss
in hypothyroidism can be reversed with treatment of the
disease.
7
At our institution, among patients with cochlear-vestibular
dysfunction and symptoms of dizziness and tinnitus, the
prevalence of hyperglycemia ranges from 12 to 17%, that of
hypercholesterolemia ranges from 46 to 57%, and that of
abnormal thyroid hormone levels is around 15%. The
prevalence of each of these disorders is significantly higher
than that observed in the general population.
8-10 No
consensus has been reached regarding the prevalence of
metabolic disorders such as diabetes mellitus, hypercholes-
terolemia, hypertriglyceridemia and thyroid dysfunction
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1149among SHL patients or their influence as associated risk
factors. The aim of the present study was to determine the
percentage of SHL patients who suffered from metabolic
disorders at the time of hearing loss and to compare this
frequency with that found in the general population as
reflected by Brazilian population surveys.
MATERIALS AND METHODS
This cross-sectional study analyzed the records of patients
treated in the Sudden Hearing Loss Section of the
Otolaryngology Department of Clinic Hospital, Medical
School of the University of Sa ˜o Paulo, between January 1996
and December 2006. The study protocol was reviewed and
approved by the Research Ethics Committee (Research
Protocol N
0 1179/07, approved on April 7, 2008) and
included all patients with SHL treated at the hospital. The
inclusion criterion was sensorineural hearing loss of at least
30 dB in three or more consecutive frequencies that occurred
with sudden onset over a 72-h period. All patients were
subjected to a standard protocol that included collection of
demographic data (sex and age), a test of hearing function,
screening for the presence of vertigo and tinnitus, audio-
metric testing and imaging tests, including temporal bone
magnetic resonance or computerized tomography. The
laboratory exams included complete blood cell counts,
glucose and cholesterol levels, LDL fraction, triglycerides,
free T4 and TSH.
The following normal ranges were taken into account:
fasting glucose 70 to 110 mg/dL, cholesterol up to 200 mg/dL,
LDL up to 160 mg/dL, triglycerides up to 200 mg/dL, free T4
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distributions of the studied parameters, we used the corres-
ponding prevalences in the Brazilian population as reference
data. Based on the 1988 National Census, the prevalence of
diabetes mellitus is 7.6% among people aged 30 to 69 years.
11
According to the Brazilian National Alert Campaign, the
prevalence of hypercholesterolemia is 40% among adults
older than 18 years (44.7 ¡ 15.7 years).
12 Based on data from
health care providers, the prevalence of dyslipidemia among
adults aged $ 20 years is 30.4% for LDL levels greater than
160 mg/dL and 17.8% for triglyceride levels greater than
200 mg/dL.
13 The rate of thyroid disorders is 10%.
14
Statistical analysis included x
2 tests, independent samples
t-tests for the differences between means by age group and
determination of the confidence intervals (CI) for the
differences between two proportions (e.g., frequency of
metabolic disorders between SHL patients and the Brazilian
population). A p value of less than 5% was considered
significant.
RESULTS
The sample comprised 166 patients with SHL, 73 men
(43.9%) and 93 (56.1%) women, mean age ¡ SD = 46.5 ¡
16.2 years. The SHL was unilateral in 157 patients (94.6%)
and bilateral in 9 (5.4%).
Testing of blood samples revealed normal glucose levels
in 136 (82.4%) patients and hyperglycemia in 29 (17.6%)
patients; one sample was lost. To homogenize our sample
with the Brazilian survey,
11 taking into account age data, we
considered only SHL patients aged 30 to 69 years. Using
these criteria, we observed 101 (81.5%) patients with normal
glucose levels and 23 patients with hyperglycemia (18.5%)
(Figure 1). Comparing this proportion with the historical
reference value for diabetes mellitus prevalence among the
Brazilian population, statistical analysis showed a signifi-
cant difference in the frequency of hyperglycemia in
patients with SHL (p , 0.0001, chi-square), with a difference
between the two proportions of 0.1338 and a 95% CI of the
difference between 0.0691 and 0.1984. Of the hyperglycemic
patients, 14 were male and 9 were female, representing
11.2% and 7.2% of the SHL samples, respectively.
Total cholesterol levels were normal in 78 (49.7%) of the
SHL patients, whereas hypercholesterolemia was observed
in 79 (50.3%); nine samples were lost. Comparison between
Figure 1 - Prevalence of hyperglycemia in patients with sudden deafness and in the general population.
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15
showed no significant difference in terms of mean age (p =
0.1579, unpaired t test) or standard deviation (p = 0.5565,
unpaired t test). There was an increase on the prevalence of
hypercholesterolemia in the SHL patient sample compared
to the historical reference value for the Brazilian population.
The statistical analysis showed a significant difference in the
frequency of hypercholesterolemia in patients with SHL
(p = 0.0093, chi-square).
15 The difference between the two
proportions was 0.0498, with a 95% CI of the difference
between 0.0098 and 0.0899.
The LDL fraction was normal in 124 (79.5%) of the SHL
patients, whereas hyperlipidemia was observed in 32
(20.5%); 10 samples were lost. To homogenize our sample
with that used in the Brazilian survey
13, taking into account
age data, we considered only SHL patients aged more
than 20 years. Within this group of patients, 118 (79.7%)
had normal LDL levels and 30 (20.3%) exhibited LDL $
160 mg/dL. Compared to the historical reference value
for hypercholesterolemia prevalence among the Brazilian
population,
13 statistical analysis showed no difference in
frequency between the two proportions (p = 0.1087, chi-
square).
Normal levels of serum triglycerides were observed in 122
(79.2%) patients, and abnormal levels were observed in 32
(20.8%); 12 samples were lost. Again, to homogenize our
sample with the Brazilian survey
13, we considered only SHL
patients aged more than 20 years; within this group, 115
(78.3%) patients had normal triglyceride levels, and 32
(21.7%) had triglyceride levels greater than 200 mg/dL.
Compared to the historical reference value for hypertrigly-
ceridemia prevalence among the Brazilian population,
13
statistical analysis showed no difference in frequency (p =
0.1474, chi-square).
With respect to thyroid hormones, normal levels were
observed in 116 (78.4%) patients, whereas 32 (21.6%) had
abnormal levels; 18 samples were lost (Figure 2). Statistical
analysis showed a significant difference in the frequency of
thyroid disorders among patients with SHL and the
historical reference value for thyroid disorder prevalence
in the population (p = 0.0132), with a difference between
the two proportions of 0.1988 and a 95% CI of the difference
between 0.0359 and 0.3616. Of the patients exhibiting
abnormal levels of thyroid hormones, 25 (78.1%) were
female and 7 were male (21.9%). Subclinical hypothyroidism
accounted for 17 cases (11.5% of the total SHL population),
subclinical hyperthyroidism accounted for 13 cases (8.8%),
and overt hypothyroidism accounted for 2 cases (1.3%).
DISCUSSION
Our study corroborates previous findings that among
patients with SHL, mean age ranges from 43 to 53 years,
gender distribution is even, and hearing loss is unilateral in
over 95% of cases.
16
According to data from the National Ministry of Health
and a multicenter cross-sectional survey, the prevalence of
diabetes mellitus and impaired glucose tolerance in the
urban Brazilian population aged 30 to 69 years is 7.6% and
7.8%, respectively.
11,17 The prevalence of diabetes mellitus is
similar between females (7.6%) and males (7.5%) and
increases with age, being 11.6% in the age group above
70 years of age and 0.1% in the age group below 30 years of
age. Among SHL patients, we observed a significantly
higher frequency of hyperglycemia, i.e., more than twice
that expected for the Brazilian population. We also found
that a greater proportion of males than females in the SHL
population were affected by hyperglycemia, even within the
patient age range used in the Brazilian survey.
11 These data
are in agreement with those of previous studies that show a
higher frequency of glucose disorders in patients suffering
from dizziness and/or tinnitus than in the general popula-
tion.
8-9 In a retrospective study of 148 idiopathic SHL
patients, 16.2% of whom had type 2 diabetes mellitus, Fukui
et al. found a similar frequency of hyperglycemia compar-
ing to our own findings on the frequency within the SHL
population.
18
Figure 2 - Prevalence of thyroid disorders in patients with sudden deafness and in the general population.
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deafness is not well understood, but we can presume based
on in vivo experimental studies that fluctuations in serum
glucose lead to changes in serum osmolarity that interfere
with outer hair cell motility and function, impairing
cochlear microphonics.
2,19 According to Lisowska et al.,
changes in cochlear micromechanics and in the retroco-
chlear auditory pathway are present as subclinical hearing
impairment in diabetic patients.
20 In a clinical trial using
auditory brainstem responses (ABR), peripheral transmis-
sion time (wave I) and central transmission time (interpeak
latencies I-V) were significantly delayed, and the mean
amplitudes of the distortion product otoacoustic emissions
(DPOAEs) were significantly reduced in diabetic patients
presenting normal hearing compared with control sub-
jects.
20 We also know from in vitro studies that glucose
utilization is high during cochlear development and that
inner and outer hair cells are susceptible to oxygen and
glucose deprivation.
21-22 According to Amarjargal et al., loss
of hair cells occurs during conditions of glucose deprivation,
with inner hair cells being more vulnerable than outer hair
cells.
22 These data are also supported by epidemiological
evidence from the American National Health Survey
showing that hearing impairment is more prevalent among
adults with diabetes (21.3%) compared to those without the
disease (9.4%).
3 A thirty-year national epidemiological
survey that included four distinct samples analyzed the
trends of sudden deafness in Japan.
23 The authors observed
that the number of SHL patients had increased more than
eight-fold over the past 30 years (4,000 in 1972 versus 35,000
in 2001). The most significant finding of this study was that
patients with sudden deafness exhibited diabetes mellitus
more frequently in the most recent survey than in the first
survey.
23
In a Brazilian national survey of 81,262 individuals with a
median age of 44.7 ¡ 15.7 years, a total cholesterol level
greater than 200 mg/dL was observed in 40% of the
population studied (38% of males and 42% of females); the
frequency of elevated cholesterol was higher in older age
groups.
12 Among SHL patients, we observed a significantly
higher frequency of hypercholesterolemia than that expected
for the Brazilian population. However, for LDL fraction and
triglyceride levels, the differences observed were not signifi-
cant; thus, we do not consider these two prevalences to be
different. Evidence from experimental studies demonstrates
the influence of hyperlipidemia on hearing function.
24-25
Experimental chronic hypercholesterolemia metabolically
stresses inner ear tissue, inducing cochlear glycogen
accumulation and edema in both the stria vascularis and
outer hair cells.
24 Ultrastructural morphological changes
resulting from these conditions occur mainly in the basal
cochlear turn and are associated with auditory dysfunction
observed in ABR, in which reduced hearing sensitivity is
observed in response to a cholesterol-supplemented diet.
25
Vascular occlusion has also been suggested as a possible
mechanism by which hyperlipidemia may contribute to an
increased risk of SHL pathogenesis.
5 In a clinical case-
control study of 155 SHL patients and 155 controls, a
multivariate analysis showed cholesterol levels to be an
independent acquired risk factor 4.8 times more likely to be
associated with the SHL population than with controls,
indirectly supporting the vascular hypothesis.
5 In a case-
control study based on audiometric, ABR and transient-
evoked otoacoustic emission (TEOAE) evaluations of
patients suffering from hypercholesterolemia and hyper-
triglyceridemia, no significant differences were observed in
mean auditory thresholds between the study and control
groups.
4 However, ABR evaluation showed prolonged
latencies of the III and V waves, as well as prolonged I-III
and III-V interpeak latencies, in the patients with hyper-
lipidemia in comparison with the control group.
4 In another
case-control study, the occurrence of hyperinsulinemia,
diabetes mellitus, and hyperlipidemia was assessed in
patients suffering from vertigo, tinnitus, or hearing loss of
unknown origin; only hyperlipidemia seemed not to differ
between patients and control subjects.
26 With respect to
hyperlipidemia, an opposite finding reported for the
dizziness and tinnitus group implicates high levels of serum
cholesterol in individuals with vestibular and cochlear
complaints compared to the historical reference prevalence
expected for the Brazilian population.
8-9 In another clinical
study, mean hearing levels in patients with chronic-phase
SHL and hyperlipidemia, as diagnosed by serum cholesterol
levels greater than or equal to 230 mg/dL, improved
significantly after therapy with diet and the administration
of antilipidemic agents.
27 Although it is controversial in the
literature, prevailing evidence seems to suggest that
hyperlipidemia may have an influence on hearing function,
although the data are not clear for SHL patients.
Subclinical hypothyroidism isdefinedasanelevated serum
level of thyroid-stimulating hormone (TSH) and normal free
thyroid hormone values. The prevalence of subclinical hypo-
thyroidism in the American general population aged up to
12 years is 4 to 8%; the condition is significantly higher in
females (5.8%) than in males (3.4%) and increases with age,
especially beyond the age of 60.
28 Subclinical hyperthyroi-
dism is much less common than subclinical hypothyroidism;
3.2% of the population has TSH levels below 0.4 uU/L.
29 In
our sample, we observed a greater proportion of females than
males affected by abnormal thyroid hormone levels. In
addition, our sample as a whole exhibited a greater propor-
tion of abnormal thyroid hormone levels than is reported for
the general population. Taking into account that the pre-
valence of thyroid impairment in the general population is
about 10%, we found a significantly higher frequency, more
thantwiceashighasexpected,inoursample.
14 Similar results
were obtained in a previous cross-sectional study of patients
with dizziness.
8 Taken together, these observations suggest
that thyroid hormone levels may play a role in cochlear-
vestibular function. In a multivariate linear regression study
carried out using data collected over more than 20 years from
52 patients with SHL, Narozny et al. observed subclinical
hyperthyroidism (low levels of TSH) in 15.4% of the cases,
and this parameter was found to be a negative prognostic
factor for hearing outcome.
30 Although we found a somewhat
lower frequency of subclinical hyperthyroidism in our
sample, this difference may be due to the sample size. Our
results agreewith those of Naroznyetal. in that the frequency
of thyroid dysfunction may be two to four times higher
among patients with SHL than that observed in the general
population. In a case-control study with 109 patients,
Nakashima et al. investigated risk factors for idiopathic
SHL, and personal history of thyroid disease appeared to be
significantly associated with SHL risk.
31 Another multivariate
linear regression study that analyzed two groups of SHL
patients undergoing different treatments showed that normal
thyroid function was a positive prognostic factor for hearing
recovery.
32
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1152CONCLUSIONS
Hyperglycemia and thyroid disorders are much more
frequent in patients with sudden deafness than in the
general population and should be considered as important
associated risk factors for sudden deafness.
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